Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$522.38 +6.04 (+1.17%)
At close: Sep 24, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Cash & Equivalents Growth (3y) (2012 - 2026)

Analysis

Vertex Pharmaceuticals (VRTX) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -1.21%
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -9.15%
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 6.56%
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -11.22%
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -4.76%
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -25.80%
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -17.71%
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -28.16%
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -15.41%
10 Bristol Myers Squibb 124.95 Bn 113.89 Bn 9.25 Bn 1.37%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.41%
Mar 31, 2026 -16.07%
Dec 31, 2025 -21.48%
Sep 30, 2025 -18.64%
Jun 30, 2025 -17.02%
Mar 31, 2025 -14.96%
Dec 31, 2024 -12.39%
Sep 30, 2024 -5.84%
Jun 30, 2024 -8.93%
Mar 31, 2024 13.25%
Dec 31, 2023 20.08%
Sep 30, 2023 27.52%
Jun 30, 2023 28.08%
Mar 31, 2023 37.25%
Dec 31, 2022 50.05%
Sep 30, 2022 39.23%
Jun 30, 2022 38.23%
Mar 31, 2022 37.97%
Dec 31, 2021 36.87%
Sep 30, 2021 36.30%
API Access

Vertex Pharmaceuticals Cash & Equivalents Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-3y&ticker=VRTX&period=max&api_key=YOUR_API_KEY